The interleukin 1 receptor: Ligand interactions and signal transduction

被引:147
作者
Auron, PE
机构
[1] Harvard Univ, Sch Med, Harvard Inst Med, Dept Pathol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Harvard Inst Med, New England Baptist Bone & Joint Inst, Boston, MA 02115 USA
关键词
ligand-receptor interaction and structure cytokine signaling; transcription factor activation; signal transduction; interleukin; 1; IL-1; inflammation;
D O I
10.1016/S1359-6101(98)00018-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interleukin 1 (IL-1) receptor is a critical component in mediating the inflammatory responses of IL-1, which affect nearly every cell type. Recently, major inroads have been made toward understanding the mechanism by which IL-1 interacts with its receptor and activates signal transduction. The receptor-ligand association has been visualized by X-ray crystal structure analysis, revealing intimate details that distinguish IL-1 beta from the naturally-occurring receptor antagonist. Signaling studies have focused primarily on the ability of IL-1 to transduce the activation of the transcription factor, NF-kappa B, which is of central importance to inflammatory and immune responses. Virtually all of the effort has targeted the activation of a kinase which results in the phosphorylation of the inhibitory I kappa B molecule at two serines that precedes the proteolytic degradation of this inhibitor and the release of active NF-kappa B, The recent characterization of an IL-1 receptor associated kinase (IRAK) and a continuous molecular path between this kinase and that which directly phosphorylates I kappa B would seem to all but close the basic understanding of IL-1 receptor signal transduction, However, at least half of the IL-1-dependent NF-kappa B activation is independent of IRAK and uses a novel pathway involving the recruitment of phosphatidylinositol 3-kinase (PI3K) to a distinct site within the cytoplasmic domain of the IL-1 receptor. This novel pathway for NF-kappa B activation and the fact that other important transcription factors are also activated by an IL-1 receptor-dependent signal event, clearly defines additional mechanisms that influence inflammation. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:221 / 237
页数:17
相关论文
共 92 条
[1]   A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY [J].
AKIRA, S ;
ISSHIKI, H ;
SUGITA, T ;
TANABE, O ;
KINOSHITA, S ;
NISHIO, Y ;
NAKAJIMA, T ;
HIRANO, T ;
KISHIMOTO, T .
EMBO JOURNAL, 1990, 9 (06) :1897-1906
[2]   12-O-TETRADECANOYL-PHORBOL-13-ACETATE INDUCTION OF THE HUMAN COLLAGENASE GENE IS MEDIATED BY AN INDUCIBLE ENHANCER ELEMENT LOCATED IN THE 5'-FLANKING REGION [J].
ANGEL, P ;
BAUMANN, I ;
STEIN, B ;
DELIUS, H ;
RAHMSDORF, HJ ;
HERRLICH, P .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (06) :2256-2266
[3]   MULTIPLE AMINO-ACID SUBSTITUTIONS SUGGEST A STRUCTURAL BASIS FOR THE SEPARATION OF BIOLOGICAL-ACTIVITY AND RECEPTOR-BINDING IN A MUTANT INTERLEUKIN-1-BETA PROTEIN [J].
AURON, PE ;
QUIGLEY, GJ ;
ROSENWASSER, LJ ;
GEHRKE, L .
BIOCHEMISTRY, 1992, 31 (29) :6632-6638
[4]   NUCLEOTIDE-SEQUENCE OF HUMAN MONOCYTE INTERLEUKIN-1 PRECURSOR CDNA [J].
AURON, PE ;
WEBB, AC ;
ROSENWASSER, LJ ;
MUCCI, SF ;
RICH, A ;
WOLFF, SM ;
DINARELLO, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (24) :7907-7911
[5]  
AURON PE, 1994, EUR CYTOKINE NETW, V5, P573
[6]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[7]  
Baker SJ, 1996, ONCOGENE, V12, P1
[8]   A newly defined interleukin-1? [J].
Bazan, JF ;
Timans, JC ;
Kastelein, RA .
NATURE, 1996, 379 (6566) :591-591
[9]   STAT3 ACTIVATION BY CYTOKINES UTILIZING GP130 AND RELATED TRANSDUCERS INVOLVES A SECONDARY MODIFICATION REQUIRING AN H7-SENSITIVE KINASE [J].
BOULTON, TG ;
ZHONG, Z ;
WEN, ZL ;
DARNELL, JE ;
STAHL, N ;
YANCOPOULOS, GD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (15) :6915-6919
[10]   MyD88, an adapter protein involved in interleukin-1 signaling [J].
Burns, K ;
Martinon, F ;
Esslinger, C ;
Pahl, H ;
Schneider, P ;
Bodmer, JL ;
Di Marco, F ;
French, L ;
Tschopp, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :12203-12209